Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylases inhibitor MS‐275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway
Shanshan Ma, Tengfei Liu, Ling Xu, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 22400-22410
Closed Access | Times Cited: 25

Showing 25 citing articles:

Aging and age‐related diseases: from mechanisms to therapeutic strategies
Zhe Li, Zhenkun Zhang, Yikun Ren, et al.
Biogerontology (2021) Vol. 22, Iss. 2, pp. 165-187
Open Access | Times Cited: 420
Co‐delivery Nano System of MS‐275 and V‐9302 Induces Pyroptosis and Enhances Anti‐Tumor Immunity Against Uveal Melanoma
Hong Ren, Zhenkai Wu, Jia Tan, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 8
Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116873-116873
Open Access | Times Cited: 4
Identification of Hub Genes Contribute to both Stemness and ER/PR Deprivation in Breast Cancer
H.S. Shang, Tao Xu
(2025), pp. 358-370
Closed Access
Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation
Qiao Xiao, Xiangyu Wu, Shutong Chen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 9
PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming
Yingchao Ma, Xishen Zhang, Xiao Yu Han, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 6, pp. 866-881
Closed Access | Times Cited: 8
Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex
Dongnan Ping, Xiaofan Pu, Guoping Ding, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 2, pp. 194941-194941
Closed Access | Times Cited: 8
Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo
Karin Schelch, Dominik Emminger, Benjamin Zitta, et al.
Cancer Letters (2023) Vol. 574, pp. 216395-216395
Open Access | Times Cited: 8
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
Yingjie Wang, Hongyu Liu, Mengsha Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells
Tengfei Liu, Fangxia Guan, Yaping Wang, et al.
Toxicology and Applied Pharmacology (2020) Vol. 395, pp. 114971-114971
Closed Access | Times Cited: 16
Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway
Luquan Zhang, Hao Liang, Yanzhong Xin
Anti-Cancer Drugs (2020) Vol. 31, Iss. 8, pp. 847-855
Closed Access | Times Cited: 16
Epigenetics and therapeutic targets in gastrointestinal malignancies
Ganji Purnachandra Nagaraju, Prameswari Kasa, Begum Dariya, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2303-2314
Closed Access | Times Cited: 14
CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification
Yingkuan Liang, Qixing Mao, Lin Wang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 13
Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model
Yeeun Kim, Kyunghee Park, Yeon Jeong Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15539-15539
Open Access | Times Cited: 9
Sodium Valproate, a Histone Deacetylase Inhibitor, Provokes Reactive Oxygen Species–Mediated Cytotoxicity in Human Hepatocellular Carcinoma Cells
Prabakaran Rithanya, Devaraj Ezhilarasan
Journal of Gastrointestinal Cancer (2020) Vol. 52, Iss. 1, pp. 138-144
Closed Access | Times Cited: 13
HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10
Jindong Li, Chengyan Jin, Lihua Sun, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches
Parul Ahuja, Ritu Yadav, Sandeep Goyal, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 6, pp. 2437-2465
Closed Access | Times Cited: 4
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Nair Lopes, Sofia Salta, Bianca Troncarelli Flores, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Polyamine homeostasis-based strategies for cancer: The role of combination regimens
Qizhang Li, Zanwen Zuo, Zerong Zhou, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174456-174456
Closed Access | Times Cited: 9
Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics
Long Liao, Ziting Yao, Wang‐Kai Fang, et al.
Small Methods (2020) Vol. 4, Iss. 10
Closed Access | Times Cited: 8
Up-regulation of SOCS4 promotes cell proliferation and migration in esophageal squamous cell carcinoma
Jie Ying, Huan-Huan Huang, Miaomiao Zhang, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 5, pp. 2416-2427
Open Access | Times Cited: 7
Development and treatment of colorectal cancer: Insights from multi‐kingdom microbiota
Yue‐Mei Hong, Dingka Song, Ning‐Ning Liu, et al.
Aging and Cancer (2023) Vol. 4, Iss. 1, pp. 21-40
Open Access | Times Cited: 2
ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
Hui Yin, Lunqing Wang, Fei Li, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 5, pp. 3282-3292
Open Access | Times Cited: 4
Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
Yang Shi, Meiqi Wang, Dan Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Future epigenetic treatment strategies
Lingyue Gao, Lihui Wang
Elsevier eBooks (2021), pp. 103-119
Closed Access
Page 1

Scroll to top